000 | 01128 a2200349 4500 | ||
---|---|---|---|
005 | 20250518022738.0 | ||
264 | 0 | _c20191011 | |
008 | 201910s 0 0 eng d | ||
022 | _a1476-5594 | ||
024 | 7 |
_a10.1038/s41388-019-0712-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHepburn, A C | |
245 | 0 | 0 |
_aThe induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance. _h[electronic resource] |
260 |
_bOncogene _c05 2019 |
||
300 |
_a4412-4424 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
700 | 1 | _aSteele, R E | |
700 | 1 | _aVeeratterapillay, R | |
700 | 1 | _aWilson, L | |
700 | 1 | _aKounatidou, E E | |
700 | 1 | _aBarnard, A | |
700 | 1 | _aBerry, P | |
700 | 1 | _aCassidy, J R | |
700 | 1 | _aMoad, M | |
700 | 1 | _aEl-Sherif, A | |
700 | 1 | _aGaughan, L | |
700 | 1 | _aMills, I G | |
700 | 1 | _aRobson, C N | |
700 | 1 | _aHeer, R | |
773 | 0 |
_tOncogene _gvol. 38 _gno. 22 _gp. 4412-4424 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41388-019-0712-y _zAvailable from publisher's website |
999 |
_c29350866 _d29350866 |